Christopher H. van Dyck

Statistics

Publications

Citations

H-Index

Active since

2000

Affiliations

Christopher H. van Dyck is an author at Yale University specializing in pharmacological treatment of dementia, cognitive impairment, and dementia treatment.

Publications per year

2000–2025

Publications

Extended-release physostigmine in Alzheimer disease: a multicenter, double-blind, 12-week study with dose enrichment. Physostigmine Study Group.

Christopher H. van Dyck · PubMed · 2000 · 30 citations

Medicine, Pharmacology, Pharmacotherapy +17

Long‐term safety and efficacy of lecanemab in early Alzheimer's disease: Results from the clarity AD open‐label extension study

Christopher H. van Dyck, Reisa Sperling, Keith A. Johnson et al. · Alzheimer s & Dementia · 2025 · 21 citations · Full text

Medicine, Neurology, Pharmacotherapy +17

1–2 of 2